This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Why NuPathe Inc. (PATH) Is Up Today

NEW YORK  ( TheStreet) --  NuPathe, Inc.  (PATH) soared 36% to $4.40 a share when the market opened Wednesday morning after Teva Pharmaceuticals Industries, Inc. (TEVA) offered at least $114 million to acquire the U.S. migraine treatment producer. The stock traded at a volume of nearly 3.8 million compared to its average volume of approximately 460,000.

Teva's move is to outbid Endo Health Solutions, Inc. (ENDP), which announced on Dec. 16 a $105 million cash offer plus a maximum of $3.15 a share if certain sales goals are met. Teva offered to pay $3.65 a share plus a maximum of $3.15 a share if the migraine drug Zecuity reaches its sales goals, according to Bloomberg. NuPathe's board has yet to decide if Teva's offering is better than Endo's.

The U.S. approved Zecuity in 2013. The drug uses a battery-powered patch to treat patients through the skin. NuPathe is also working on products to treat bipolar disorder, Parkinson's, schizophrenia and other neurological disorders.


PATH Chart

PATH data by YCharts

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
PATH $0.00 0.00%
AAPL $130.28 0.00%
FB $81.53 0.00%
GOOG $565.06 0.00%
TSLA $218.42 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs